Evidence map›Paper›PMID 38776385›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2024

Research Advances in Abdominal Aortic Aneurysms: Triglyceride-Rich Lipoproteins as a Therapeutic Target.

Hong S Lu, Ryan E Temel, Michael G Levin, Scott M Damrauer, Alan Daugherty

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hong S LuSaha Cardiovascular Research Center (H.S.L., R.E.T., A.D.), College of Medicine, University of Kentucky, Lexington.ORCID 0000-0002-0577-2558
Ryan E TemelSaha Cardiovascular Research Center (H.S.L., R.E.T., A.D.), College of Medicine, University of Kentucky, Lexington.
Michael G LevinDepartments of Medicine (M.G.L.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.ORCID 0000-0002-9937-9932
Scott M DamrauerSurgery (S.M.D.), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Alan DaughertySaha Cardiovascular Research Center (H.S.L., R.E.T., A.D.), College of Medicine, University of Kentucky, Lexington.ORCID 0000-0003-2093-3775

Funding

Kentucky Center for Clinical and Translational ScienceUL1TR001998 · NCATS · UNIVERSITY OF KENTUCKY · PI HARTMANN, KATHERINE E, KERN, PHILIP A · 2016 to 2025
$34.2M
Determinants of Aorta HeterogeneityR35HL155649 · NHLBI · UNIVERSITY OF KENTUCKY · PI Alan Daugherty · 2021 to 2026
$5.3M
Impact of PCSK9 inhibition on abdominal aortic aneurysm pathobiology and growthR01HL166991 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Scott Michael Damrauer · 2023 to 2026
$2.6M
NCATS NIH HHS UL1 TR001998NHLBI NIH HHS R01 HL166991NHLBI NIH HHS R35 HL155649
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aortic Aneurysm, AbdominalLipoproteinsTriglyceridesAnimalsHumansHypolipidemic AgentsHypolipidemic AgentsLipoproteinslipoprotein triglycerideTriglyceridesaortic aneurysm, abdominalhyperlipidemiaslipoproteinsmicetriglycerides

Identifiers

PMID38776385
PMCPMC11112677

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.